Comparison of safety and immunogenicity of two doses of investigational hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age.
Vaccine , 2012;30:2556–2563. doi: 10.1016/j.vaccine.2012.01.087